Literature DB >> 12974262

Utility of the MELD score for assessing 3-month survival in patients with liver cirrhosis: one more positive answer.

Edoardo Giannini, Federica Botta, Roberto Testa.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 12974262     DOI： 10.1016/s0016-5085(03)01147-8

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  3 in total

1.  Predicting Mortality Across a Broad Spectrum of Liver Disease-An Assessment of Model for End-Stage Liver Disease (MELD), Child-Turcotte-Pugh (CTP), and Creatinine-Modified CTP Scores.

Authors:  Yogesh K Chawla; Ramesh Chillal Kashinath; Ajay Duseja; Radha K Dhiman
Journal:  J Clin Exp Hepatol       Date:  2012-01-02

2.  Use of the Model for End-Stage Liver Disease (MELD) score to predict 1-year survival of Japanese patients with cirrhosis and to determine who will benefit from living donor liver transplantation.

Authors:  Masatoshi Ishigami; Takashi Honda; Akihiko Okumura; Tetsuya Ishikawa; Makoto Kobayashi; Yoshiaki Katano; Yasuhiro Fujimoto; Tetsuya Kiuchi; Hidemi Goto
Journal:  J Gastroenterol       Date:  2008-07-01       Impact factor: 7.527

3.  Pretransplant prediction of posttransplant survival for liver recipients with benign end-stage liver diseases: a nonlinear model.

Authors:  Ming Zhang; Fei Yin; Bo Chen; You Ping Li; Lu Nan Yan; Tian Fu Wen; Bo Li
Journal:  PLoS One       Date:  2012-03-01       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.